Compositions and methods for reducing background DNA amplification

US9546358B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9546358-B2
Application numberUS-201313799463-A
CountryUS
Kind codeB2
Filing dateMar 13, 2013
Priority dateJun 4, 2012
Publication dateJan 17, 2017
Grant dateJan 17, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compositions are provided that include a plurality of small molecules selected from the group consisting of an amide, urea or acetone having a molecular weight less than 300 g/mol; and dNTPs and a polymerase in a buffer suitable for use as an amplification buffer. Methods of use of the compositions are also described for reducing non-template DNA amplification.

First claim

Opening claim text (preview).

What is claimed is: 1. A method comprising: (a) producing a reaction mixture by combining: (i) a carboxamide selected from the group consisting of formamide, acetamide, propionamide, butyramide, isobutryamide, valeramide and hexanamide; and an N-alkylcarboxamide selected from the group consisting of N-methylformamide, N-methylacetamide, N,N-dimethylformamide, N,N-diethylformamide, N,N-dimethylbutyramide, at a molar ratio in the range of 1:1 to 1:10 (carboxymide:N-alkylcarboxamide), (ii) a polymerase; (iii) dNTPs; (iv) one or more primers; (v) template and non-template nucleic acid; and (vi) a DNA amplification buffer; and (b) incubating the reaction mixture under conditions to amplify the template nucleic acid, wherein the carboxamide and N-alkylcarboxamide synergistically reduce amplification of the non-template nucleic acid. 2. The method of claim 1 , wherein the carboxamide is at a concentration in the range of 0.02 M to 0.7 M and the N-alkyl carboxamide is at a concentration in the range of 0.03 M to 1.5 M. 3. The method of claim 1 , wherein the polymerase is a family A polymerase or a family B polymerase. 4. The method of claim 1 , wherein the polymerase is selected from the group consisting of Bst polymerase, PolD polymerase, KOD polymerase, mutants of the same and chimeras of the same. 5. The method of claim 1 , wherein the polymerase is a strand-displacing polymerase. 6. The method of claim 1 , wherein the conditions of step (b) are isothermal. 7. The method of claim 1 , wherein the conditions of step (b) comprise thermocycling. 8. The method of claim 1 , wherein the reaction mixture comprises isobutryamide and N-methylformamide.

Assignees

Inventors

Classifications

  • C12Q1/6848Primary

    characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction · CPC title

  • C12N9/1241Primary

    Nucleotidyltransferases (2.7.7) · CPC title

  • Specific component of sample, medium or buffer · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9546358B2 cover?
Compositions are provided that include a plurality of small molecules selected from the group consisting of an amide, urea or acetone having a molecular weight less than 300 g/mol; and dNTPs and a polymerase in a buffer suitable for use as an amplification buffer. Methods of use of the compositions are also described for reducing non-template DNA amplification.
Who is the assignee on this patent?
New England Biolabs Inc
What technology area does this patent fall under?
Primary CPC classification C12Q1/6848. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).